However, new findings indicate that inhibition of P-gp does not increase the efficacy of proteasome inhibitors in multiple myeloma cells [12] or in P-gp-positive B-cell precursor ALL cell lines [14]. The gene discussed is PGP; the disease is AL amyloidosis.